Article Text

Download PDFPDF
Heart failure resulting from cancer treatment: still serious but an opportunity for prevention

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests ARLhas received speaker, advisory board, consultancy fees and/or research grants from Pfizer, Novartis, Servier, Amgen, Clinigen Group, Takeda, Roche, Eli Lily,Eisai, Bristol Myers Squibb, Ferring Pharmaceuticals and Boehringer Ingelheim.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles